Tanezumab in Osteoarthritis of the Knee

Completed · Phase 3 · Has a placebo group

Conditions studied: Arthritis, Osteoarthritis

In brief

Test the efficacy and safety of 3 doses in Osteoarthritis of the knee in patients.

Key facts

Study ID
NCT00733902
Run by
Pfizer
People needed
697
Starts
2008-09-15
Expected to finish
2010-01-14
Last updated by the study team
2021-03-22

Who can join

Age: 18 and older, up to 99. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.